Clinical trials - Press Releases

Date	Title	Company
27-Oct-2022	Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials	Boehringer Ingelheim
27-Oct-2022	Registration is now open for RNA Therapeutics Conference 2023	SAE Media Group
27-Oct-2022	Brain Implants Market worth US$ 13.3 Billion 2029 with a CAGR of 12.4 %	Prophecy Market Insights
27-Oct-2022	Prosthetics Market is estimated to be US$ 9.44 billion by 2030 with a CAGR of 4.5% during the forecast period 2030	Prophecy Market Insights
26-Oct-2022	CARMAT announces that it has received regulatory approvals to resume its clinical study in France	CARMAT
26-Oct-2022	New Analysis of UPLIZNA® (inebilizumab) Phase 3 Trial Data Demonstrates Importance of Reducing Plasmablasts to Help Prevent Neuromyelitis Optica Spectrum Disorder (NMOSD) Attacks	Horizon Therapeutics plc
21-Oct-2022	Speeding up trial enrolment can save billions	Panthera Biopartners
18-Oct-2022	1ST Biotherapeutics, Inc., Announces Positive Phase I Data of c-Abl Inhibitor in Neurodegeneration	1ST Biotherapeutics, Inc.
18-Oct-2022	AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program	AcuraBio
17-Oct-2022	The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval	Novotech Health Holdings Pte Ltd
17-Oct-2022	XBiotech Announces First Patient Enrolled into the French National Cancer Institute (INCA) Sponsored Phase I/II/III Clinical Study for Natrunix™ Therapy for Colorectal Cancer	XBiotech
14-Oct-2022	New Medidata Technology Helps Sponsors and CROs Improve Diversity and Inclusion in Clinical Trials	Medidata
12-Oct-2022	RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials	CluePoints
12-Oct-2022	Tiziana Life Sciences Plans to Submit IND for Phase 1 Trial of Intranasal Foralumab in Alzheimer's Disease Patients	Tiziana Life Sciences
12-Oct-2022	InfanDx AG Reports Successful Validation of Biomarker Panels for the Early Detection of Hypoxic Ischemic Encephalopathy	InfanDx AG
11-Oct-2022	Albireo Reports Positive Topline Data from Phase 3 Trial of Bylvay® (odevixibat) in Alagille Syndrome	Albireo Pharma
11-Oct-2022	Pistoia Alliance Launches Global Community of Interest to Assess the Environmental Impact of Clinical Trials	Pistoia Alliance
11-Oct-2022	Renowned experts join Ultrahuman as it kicks off clinical trials on glucose	Ultrahuman
11-Oct-2022	TILT Biotherapeutics Announces First US Patient Dosed in Immunotherapy Clinical Trial in Ovarian Cancer	TILT Biotherapeutics
11-Oct-2022	Dupixent® (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old	Sanofi